MDA-MB-231 was used to generate stable PLD3-overexpression cells (231-PLD3) and control cells (231-Vector) via lentiviral infection (Fig. 1A) to explore the potential role of PLD3 in breast cancer progression. This evidence concerns the gene PLD3 and breast carcinoma.